Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from EuroEyes International Eye Clinic Limited ( (HK:1846) ).
EuroEyes International Eye Clinic Limited reported a decline in the total number of eye surgeries for the fourth quarter and the entire year of 2024. The decrease is primarily due to reduced demand for myopia correction surgeries, although the company’s emphasis on presbyopia correction surgeries has helped mitigate some of the impact. EuroEyes remains optimistic about a return to growth, supported by its resilient business model, while remaining cautious about the immediate future.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited operates in the healthcare industry, specializing in eye surgeries. The company focuses on myopia and presbyopia correction surgeries, providing services to a market that values advanced vision correction techniques.
YTD Price Performance: -17.72%
Average Trading Volume: 210,264
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$1.06B
Find detailed analytics on 1846 stock on TipRanks’ Stock Analysis page.
